By inducing autophagy in certain cancer cells, TRAIL can protect cells by blunting the cytotoxicity of the treatment, thus contributing to TRAIL resistance.118 Mir-9 is also known to interact with the TGF-β signalling pathway during EMT;119 however, information is still lacking about TRAIL sensitivity. The gene discussed is TGFB1; the disease is cancer.